YOLFTbeta
60

Yunnan Jianzhijia Health-Chain Co Ltd

605266 · SHG · Healthcare / Pharmaceutical Retailers

13.12CNY-0.29 (-2.16%)

Price History

Full chart

Market Stats

Previous Close13.41
Open13.41
Day Range13.07 – 13.46
52-Week Range14.41 – 20.76
Volume2.12M
Market Cap2.48B
P/E (TTM)18.23
Forward P/E0.00
EPS0.88
Dividend Yield7.92%
Beta0.52
50-Day Avg16.19
200-Day Avg18.17

About

Jianzhijia Pharmaceutical Chain Group Co., Ltd. engages in the pharmaceutical retail business in China. The company offers pharmaceuticals, health food, personal care products, household health products, convenience food, and daily consumables through community clinics and convenience stores. The company was formerly known as Yunnan Jianzhijia Health-Chain Co., Ltd. and changed its name to Jianzhijia Pharmaceutical Chain Group Co., Ltd. in September 2022. Jianzhijia Pharmaceutical Chain Group Co., Ltd. was founded in 1998 and is based in Kunming, China.

Company Details

  • SectorHealthcare
  • IndustryPharmaceutical Retailers
  • CEOMr. Bo Lan
  • Employees16.08K
  • HeadquartersNo. 10, Qiying Street, Kunming, China, 650224, China
  • Websitehttps://www.jzj.cn

Leadership

  • Mr. Bo LanChairman & GM · b. 1967
  • Mr. Heng LiCFO, Deputy GM, Board Secretary & Director · b. 1977
  • Ms. Yanyin JiangDeputy General Manager · b. 1970
  • Ms. Yanchun ShiDeputy General Manager · b. 1970
  • Mr. Yuming HuDeputy General Manager · b. 1966
  • Mr. Fei YangDeputy General Manager · b. 1971
  • Mr. Zhiqi ChaiDeputy General Manager · b. 1975
  • Xuejin SongAccounting Supervisor

Financials

Income Statement

Currency: CNY2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.67B1.84B2.05B2.35B2.77B3.53B4.47B5.23B7.51B9.08B9.28B8.92B
Growth (%)-+10.63%+11.36%+14.27%+17.85%+27.57%+26.58%+17.21%+43.54%+20.84%+2.23%-3.90%
Cost of Revenue1.05B1.16B1.27B1.48B1.73B2.30B2.98B3.37B4.83B5.84B5.99B5.70B
Gross Profit616.51M687.04M780.39M865.13M1.04B1.23B1.49B1.86B2.69B3.24B3.29B3.22B
Gross Margin36.98%37.25%38.00%36.86%37.44%34.80%33.36%35.57%35.73%35.64%35.44%36.14%
Operating Expense593.82M661.40M693.43M736.82M856.63M1.01B1.20B1.51B2.24B2.71B3.11B2.80B
Operating Income22.69M25.64M86.97M128.31M178.82M221.32M292.31M353.79M445.38M522.08M176.08M425.65M
Operating Margin1.36%1.39%4.23%5.47%6.47%6.27%6.54%6.76%5.93%5.75%1.90%4.77%
EBITDA52.98M48.59M111.41M156.45M206.63M253.61M330.32M439.04M602.74M723.98M384.20M1.14B
EBITDA Margin3.18%2.63%5.42%6.67%7.47%7.19%7.40%8.39%8.02%7.97%4.14%12.79%
Net Income17.35M17.97M70.88M94.88M133.63M168.12M251.15M300.53M374.29M414.41M128.13M148.15M
Net Income Margin1.04%0.97%3.45%4.04%4.83%4.76%5.62%5.74%4.98%4.56%1.38%1.66%
Interest Expense15.94M10.33M11.61M11.06M10.08M12.38M11.46M55.90M109.11M133.53M146.21M120.72M
Interest Expense % of Total Revenue0.96%0.56%0.57%0.47%0.36%0.35%0.26%1.07%1.45%1.47%1.58%1.35%

Balance Sheet

Currency: CNY2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.01B1.04B1.16B1.49B1.69B2.00B3.47B5.21B9.39B9.95B10.62B9.75B
Total Liabilities857.05M865.12M915.42M1.15B1.24B1.42B1.77B3.32B6.83B7.10B7.84B7.08B
Total Equity156.97M186.40M255.98M351.62M459.36M591.51M1.72B1.91B2.58B2.86B2.80B2.67B
Cash237.77M204.48M245.89M357.55M328.39M443.28M1.62B983.10M932.60M857.93M776.05M878.58M
Total Debt141.28M86.97M95.66M144.20M96.80M61.40M110.12M1.28B2.93B2.70B3.70B-
Net Debt-96.49M-117.51M-150.24M-213.35M-231.59M-381.88M-1.51B298.88M2.00B1.84B2.93B2.09B

Cash Flow

Currency: CNY2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow66.37M-16.33M145.42M205.51M193.21M337.60M316.64M744.40M1.19B1.02B508.98M1.17B
Investing Cash Flow-117.55M-46.92M-47.81M-154.10M-103.69M-171.85M-136.98M-724.17M-2.50B-522.54M-724.45M-
Financing Cash Flow154.03M-25.05M-89.84M40.25M-87.09M-96.75M923.16M-665.78M1.16B-663.09M5.43M-
Capital Expenditure62.90M112.19M48.01M154.55M103.94M133.22M133.07M385.53M780.68M300.04M267.92M144.56M
Free Cash Flow3.47M-128.51M97.41M50.95M89.26M204.38M183.57M358.87M409.93M724.37M241.05M1.03B
Dividends Paid20.47M7.42M5.73M4.90M33.87M37.76M4.48M121.90M120.23M144.78M241.86M242.90M
FCF to OCF5.23%787.13%66.98%24.79%46.20%60.54%57.97%48.21%34.43%70.71%47.36%87.64%
Dividend Paid to FCF589.93%-5.77%5.88%9.61%37.94%18.48%2.44%33.97%29.33%19.99%100.33%23.69%

Earnings

Report DateDec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Apr 28, 2022Aug 30, 2022Oct 28, 2022Dec 31, 2022Apr 26, 2023
EPS Estimate----------
EPS Actual0.690.560.500.630.900.330.611.061.350.77
Surprise----------
Timing-----Pre-marketPre-marketAfter-hours-Pre-market

Key Statistics & Ratios

Market Cap2.48B
Enterprise Value5.67B
Trailing P/E18.23
Forward P/E0.00
Price / Sales0.29
Price / Book0.96
EPS0.88
Book Value17.13
Revenue (TTM)8.65B
Gross Profit (TTM)3.13B
EBITDA420.14M
Profit Margin1.50%
Operating Margin2.95%
Return on Equity5.04%
Return on Assets2.31%
Shares Outstanding154.54M
Shares Float66.84M
Beta0.52
Dividend Yield7.92%
Dividend Rate1.27
Payout Ratio144.32%

Dividends

20261×
1.27Jun 12, 2026
20251×
1.10Jun 18, 2025
20241×
1.28Jun 6, 2024
20231×
1.22Jul 3, 2023
20221×
1.01Jun 8, 2022
20211×
0.87May 21, 2021

Stock Splits

  • Jun 6, 20241.2:1
  • Jul 3, 20231.3:1
  • Jun 8, 20221.3:1
  • May 21, 20211.3:1